NHS National Framework for the supply of Pomalidomide commencing 1 April 2025
Estimated value
—
goods
Awarded value
—
Suppliers
5
3 SME
Lots
1
5 awarded
Published
11 Mar 2025
Other contracts from NHS England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Matrix - Desk Booking System | call off | £105k | 08 May 2026 |
| Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028 | call off | £17k | 08 May 2026 |
| ID&V Checking Service | contract | £150k | 08 May 2026 |
| Xerox Managed Print renewal 26/27 | call off | £127k | 08 May 2026 |
| Manage Engine ServiceDesk Plus Licences | call off | £29k | 08 May 2026 |
| Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026 | contract | £105k | 08 May 2026 |
| Clinicals Run Maintain Transform | call off | £38.0m | 10 Apr 2026 |
| Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmes | contract | — | 07 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 07 Apr 2026 |
| CPIT System Integration to NHSE RAVS | contract | £500k | 01 Apr 2026 |
Other contracts awarded to Zentiva Pharma UK Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |